If you take PPIs (proton pump inhibitors), metformin, NSAIDs, or other medications that affect gut pH, motility, or the microbiome, adding Pendulum may produce unpredictable results
PIONEER 1 compared oral semaglutide with placebo [76], while PIONEER 24 compared oral semaglutide with the SGLT2i empagliflozin (25 mg once daily), the DPP-4 inhibitor sitagliptin (100 mg once daily), and the subcutaneous GLP-1RA liraglutide (1.8 mg once daily) [38, 39, 61, 62]
Testing shows what's happening at the cellular level
GLP-1s in Breast Cancer: Overall Survival, Recurrence Risk, and Safety Sherry Shen, MD Sherry Shen, MD, shares retrospective data on how GLP-1s influence overall survival and safety outcomes among patients with breast cancer
Path 1: Chronic Treatment Approach This approach treats Retatrutide as ongoing health management similar to blood pressure or cholesterol medication